HOME >> MEDICINE >> NEWS
Spinifex secures $3.25m investment to develop pain therapy

A pain drug development company spun out of The University of Queensland has received a $3.25 million investment commitment to develop its innovative new pain therapy.

Spinifex Pharmaceuticals, an emerging biotechnology company specialising in the development of therapeutics for the treatment of neuropathic pain, has attracted investment from a syndicate including Symbiosis Group Limited, Melbourne-based GBS Venture Partners Limited and Uniseed.

Spinifex Pharmaceutical Managing Director, Dr Michael Thurn said he was delighted by the investment commitment which will help to accelerate their drug development program.

"We've several promising small molecules currently under evaluation and we plan to be in a position to start a formal toxicology program on one of those molecules in 2006," said Dr Thurn.

"The two main causes of neuropathic pain are through diabetes, affecting an estimated 45 per cent of diabetics, and through complications arising from infection with herpes zoster [shingles], known as post-herpetic neuralgia.

"We see a significant world-wide market for our pain therapy, and this investment will progress our efforts in delivering a novel solution."

Spinifex's core technology relates to the discovery (made by University of Queensland researchers led by Professor Maree Smith) of a novel pathway for the treatment of neuropathic pain. Professor Smith's group successfully validated this pathway using small molecules in well-defined animal models of neuropathic pain.

Managing Director of investment company Symbiosis, Dr Mark Harvey, said Spinifex was an attractive investment, led by a strong team with extensive experience in the international and local biotechnology industry

He said the neuropathic pain market targeted by Spinifex's technology was currently valued at US$3 billion.

"With a solid intellectual property position and several 'drug-like' molecules already in hand we expe
'"/>

Contact: Dr Michael Thurn
61-7-3842-3153
Research Australia
26-Jul-2005


Page: 1 2

Related medicine news :

1. University of Rochester spin-off secures $2 million in funding
2. Medical College of Wisconsin secures key contract from US HRSA
3. Molecular Profiling Institute secures $7.5 million in Series B funding
4. Menzies secures $1.8m in funding for the NT
5. ASU secures $3.9 million to study spinal cord injuries and neurological disorders
6. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
7. New PBS investment as PBS slows
8. Industry welcomes massive Victorian investment in medical research
9. European Science Foundation warns nanomedicine benefits will be lost without major investment
10. Medicares investment in quality improvement may not be paying off
11. Baby DVDs, videos may hinder, not help, infants language development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... DETROIT (PRWEB) , ... July 17, 2019 , ... Dr. ... designed specifically for women on WJR’s Health Woman Show. The show airs on ... http://www.WomensExcellence.com/podcast after airing. , Dr. Zaidan and co-host Ann Thomas discuss the ...
(Date:7/13/2019)... ... July 13, 2019 , ... ZALO , the leading luxury sex toy ... and clitoral massager. To view the product and its accompanying video click here ... personal massagers to people around the world,” said Mara Epstein, director of sales. “The ...
(Date:7/13/2019)... ... 2019 , ... Ospitek Inc., a leading provider of healthcare ... “View”. Ospitek has partnered with some of the country’s leading surgeons, medical staff, ... specifically for surgical centers, allowing them to directly engage with patients and capture ...
(Date:7/13/2019)... ... , ... China Focus @ Bio Philadelphia , hosted ... Investment Promotion Bureau, Fox Rothschild LLP, MORE Health and Henlius, was held at ... WuXi Biologics, Kelun Pharmaceutical, Harbin Pharmaceuticals, Fountain Medical, Luye Life Science, Johnson&Johnson, Novartis, ...
(Date:7/12/2019)... ... July 12, 2019 , ... Fruit Street ... status for its diabetes prevention program from the Centers for Disease Control and ... to gain full recognition from CDC that delivers the diabetes prevention program via ...
Breaking Medicine News(10 mins):
(Date:7/18/2019)... ... 18, 2019 , ... ComplianceLine, the premier provider of whistleblower ... it is moving into new corporate headquarters in Charlotte to service accelerating growth ... moving into the new office which will allow our expanding team of compliance ...
(Date:7/17/2019)... ... ... Soliant, a leading healthcare staffing provider and part of the Adecco Group, ... Beautiful Hospital in the U.S. In Soliant’s 10th annual top 20 contest, a record ... hospitals nominated. Supporters from across the country nominated and voted for facilities they felt ...
(Date:7/17/2019)... ... July 17, 2019 , ... The Omnia-Prova Education Collaborative ... Global Learning Collaborative (GLC). , “The past few years represent the highest ... leadership, and educational collaborations,” said Rob Braun, President of GLC. “The GLC brand ...
Breaking Medicine Technology:
Cached News: